Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
cyclophosphamide nuclear receptor subfamily 1 group i member 2 small molecule NA drugbank , DGIDB Disease[MeSHID:D004194]
Adenocarcinoma[MeSHID:D000230]
Mycosis Fungoides[MeSHID:D009182]
Lymphoma[MeSHID:D008223]
leukemia[MeSHID:D007938]
Malignant neoplasm of breast[MeSHID:D001943]
Neuroblastoma[MeSHID:D009447]
Nephrotic Syndrome
Minimal Change[MeSHID:D009402]
Multiple Myeloma[MeSHID:D009101]
Retinoblastoma[MeSHID:D012175]
Ovary[MeSHID:D010053]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
0.01 approved,investigational unknown
cyclophosphamide dna small molecule NA drugbank Disease[MeSHID:D004194]
Adenocarcinoma[MeSHID:D000230]
Mycosis Fungoides[MeSHID:D009182]
Lymphoma[MeSHID:D008223]
leukemia[MeSHID:D007938]
Malignant neoplasm of breast[MeSHID:D001943]
Neuroblastoma[MeSHID:D009447]
Nephrotic Syndrome
Minimal Change[MeSHID:D009402]
Multiple Myeloma[MeSHID:D009101]
Retinoblastoma[MeSHID:D012175]
Ovary[MeSHID:D010053]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
NA approved,investigational cross-linking/alkylation
click here to return to the previous page